{"tm":1686889706,"s":"GILD","news":[{"t":"Asian American Women Engineers Find Community and Purpose at Gilead","dt":"Jun-14-23 08:15AM","a":"ACCESSWIRE","u":"https:\/\/finance.yahoo.com\/news\/asian-american-women-engineers-community-121500417.html"},{"t":"Top 20 Most Profitable Pharmaceutical Companies In The World","dt":"06:52AM","a":"Insider Monkey","u":"https:\/\/finance.yahoo.com\/news\/top-20-most-profitable-pharmaceutical-105215517.html"},{"t":"Gilead Sciences, Inc. (NASDAQ:GILD) Will Pay A US$0.75 Dividend In Four Days","dt":"06:50AM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/gilead-sciences-inc-nasdaq-gild-105002647.html"},{"t":"3 Biotech Stocks That Could Skyrocket in the Next 12 Months","dt":"08:55AM","a":"InvestorPlace","u":"https:\/\/finance.yahoo.com\/news\/3-biotech-stocks-could-skyrocket-125515518.html"},{"t":"Gilead (GILD), Arcus Announce Results From Mid-Stage NSCLC Study","dt":"Jun-05-23 02:59PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/gilead-gild-arcus-announce-results-185900415.html"},{"t":"Those who invested in Gilead Sciences (NASDAQ:GILD) a year ago are up 28%","dt":"Jun-04-23 07:00AM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/those-invested-gilead-sciences-nasdaq-110015341.html"},{"t":"Analyst Report: Gilead Sciences, Inc.","dt":"Jun-02-23 07:29AM","a":"Argus Research","u":"https:\/\/finance.yahoo.com\/m\/67a2744b-e405-3528-a3d6-1eaf54b085fb\/analyst-report%3A-gilead.html"},{"t":"Gilead and Kite Oncology Demonstrate Growing Hematology Pipeline and Strength of Leading Cell Therapy Portfolio at EHA","dt":"08:34AM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/gilead-kite-oncology-demonstrate-growing-123400085.html"},{"t":"Gilead's (GILD) Veklury Gets Positive CHMP View for Extended Use","dt":"May-26-23 10:30AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/gileads-gild-veklury-gets-positive-143000749.html"},{"t":"Gilead Sciences Stock Reaches 80-Plus Relative Strength Rating Benchmark","dt":"01:58PM","a":"Investor's Business Daily","u":"https:\/\/finance.yahoo.com\/m\/56531771-1b41-300a-8da3-331f90c5300c\/gilead-sciences-stock-reaches.html"},{"t":"14 Best Biotech Stocks To Buy According To Hedge Funds","dt":"04:03AM","a":"Insider Monkey","u":"https:\/\/finance.yahoo.com\/news\/14-best-biotech-stocks-buy-080352111.html"},{"t":"Gilead Sciences, Inc. (NASDAQ:GILD) is favoured by institutional owners who hold 85% of the company","dt":"May-21-23 10:00AM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/gilead-sciences-inc-nasdaq-gild-140013061.html"},{"t":"3 Analyst Upgrades That Smart Investors Wont Ignore","dt":"01:29PM","a":"InvestorPlace","u":"https:\/\/finance.yahoo.com\/news\/3-analyst-upgrades-smart-investors-172903518.html"},{"t":"Arcus (RCUS) &amp; Gilead Re-Collaborate for Inflammatory Diseases","dt":"09:31AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/arcus-rcus-gilead-collaborate-inflammatory-133101752.html"},{"t":"Gilead Sciences Stock: Bear vs. Bull","dt":"May-12-23 05:30AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/315b1e96-da30-363e-8418-e9228610c14e\/gilead-sciences-stock%3A-bear.html"},{"t":"15 Biggest Immunotherapy Companies in the World","dt":"May-09-23 04:09PM","a":"Insider Monkey","u":"https:\/\/finance.yahoo.com\/news\/15-biggest-immunotherapy-companies-world-200959863.html"},{"t":"Gilead Strengthens Early Pipeline in Oncology and Inflammation Through the Acquisition of XinThera","dt":"08:30AM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/gilead-strengthens-early-pipeline-oncology-123000810.html"},{"t":"InvestingPro exclusive: Vertex is a Biotech Beast + 4 More Poised to Soar","dt":"01:30AM","a":"Investing.com","u":"https:\/\/finance.yahoo.com\/news\/investingpro-exclusive-5-biotech-beasts-053018149.html"},{"t":"Gilead Sciences Stock Has Only Done This in 1 of the Past 7 Years","dt":"May-04-23 07:50AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/03a7e411-5697-34ae-9b9e-90b08443ce0b\/gilead-sciences-stock-has.html"},{"t":"Big Pharma Stocks Offer Income and Growth Potential. The Case for Gilead Sciences and Merck.","dt":"02:00AM","a":"Barrons.com","u":"https:\/\/finance.yahoo.com\/m\/8a618c08-570c-3f1a-970e-aeeb6754b56a\/big-pharma-stocks-offer.html"},{"t":"Gilead, US square off in billion-dollar HIV drug patent trial","dt":"05:00AM","a":"Reuters","u":"https:\/\/finance.yahoo.com\/news\/gilead-us-square-off-billion-090000881.html"},{"t":"Gilead Sciences (NASDAQ:GILD) sheds 5.0% this week, as yearly returns fall more in line with earnings growth","dt":"08:00AM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/gilead-sciences-nasdaq-gild-sheds-120031358.html"},{"t":"Why Gilead Sciences Stock Is Falling Today","dt":"12:29PM","a":"Benzinga","u":"https:\/\/finance.yahoo.com\/news\/why-gilead-sciences-stock-falling-162903893.html"},{"t":"Gilead Posts Bullish Cancer Drug Sales, But Profit Questions Linger","dt":"04:02PM","a":"Investor's Business Daily","u":"https:\/\/finance.yahoo.com\/m\/a7b794a1-c8d5-30c8-9a4d-a0251f1ebd9c\/gilead-posts-bullish-cancer.html"},{"t":"Better Buy: Pfizer vs. Gilead","dt":"05:30AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/b38ec47b-d5a8-33a8-8849-cd9c3f43a8aa\/better-buy%3A-pfizer-vs.-gilead.html"},{"t":"3 Cash-Rich Biotech Stocks to Bet on for the Long Haul","dt":"09:51AM","a":"InvestorPlace","u":"https:\/\/finance.yahoo.com\/news\/3-cash-rich-biotech-stocks-135115332.html"},{"t":"Will HIV and Oncology Propel Gilead's (GILD) Q1 Earnings?","dt":"Apr-21-23 12:55PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/hiv-oncology-propel-gileads-gild-165504180.html"},{"t":"Get Income On Gilead Stock, Or Buy It At A Discount With This Option Trade","dt":"10:00AM","a":"Investor's Business Daily","u":"https:\/\/finance.yahoo.com\/m\/00794dc8-2b84-3423-99eb-59802b500aa3\/get-income-on-gilead-stock%2C.html"},{"t":"Gilead Sciences: Breaking Down Barriers To Access in HIV and Beyond: A Perspective","dt":"08:55AM","a":"ACCESSWIRE","u":"https:\/\/finance.yahoo.com\/news\/gilead-sciences-breaking-down-barriers-125500464.html"},{"t":"Veklury\u00ae (Remdesivir) Efficacy and Safety Profile Further Demonstrated in Vulnerable Patient Populations","dt":"Apr-16-23 04:00AM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/veklury-remdesivir-efficacy-safety-profile-080000020.html"},{"t":"Gilead Sciences, Inc. (NASDAQ:GILD) is a favorite amongst institutional investors who own 84%","dt":"07:00AM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/gilead-sciences-inc-nasdaq-gild-110030952.html"},{"t":"Could Gilead Sciences Stock Help You Become a Millionaire?","dt":"05:31AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/8019d469-1bab-3c71-a4b9-4636743304bb\/could-gilead-sciences-stock.html"},{"t":"Is Gilead Sciences, Inc. (NASDAQ:GILD) Trading At A 49% Discount?","dt":"Apr-09-23 10:00AM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/gilead-sciences-inc-nasdaq-gild-140012770.html"}]}